This article is intended for primary care clinicians, nephrologists, endocrinologists, and other specialists who care for patients with chronic kidney disease not requiring dialysis.
The goal of this activity is to provide medical news to primary care clinicians and other healthcare professionals in order to enhance patient care.
Upon completion of this activity, participants will be able to:
As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 0.25
AMA PRA Category 1 Credit(s)™
. Physicians should only claim credit commensurate with the extent of their participation in the activity. Medscape Medical News has been reviewed and is acceptable for up to 300 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins 09/01/07. Term of approval is for 1 year from this date. This activity is approved for 0.25 Prescribed credits. Credit may be claimed for 1 year from the date of this activity. AAFP credit is subject to change based on topic selection throughout the accreditation year.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 5 years; at any point within this time period you can print
out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.
*The credit that you receive is based on your user profile.
CME Released: 6/11/2008
Valid for credit through: 6/11/2009
processing....
June 11, 2008 — Many patients with chronic kidney disease have mild reductions in thyroid function, or subclinical hypothyroidism, which becomes more common as kidney function declines, according to the results of a study reported in the June 11 Online First issue of the Clinical Journal of the American Society of Nephrology.
"Subclinical primary hypothyroidism is highly prevalent in the general population, especially in the elderly," write Michel Chonchol, MD, from the University of Colorado Health Sciences Center in Denver, and colleagues. "However, the prevalence of subclinical primary hypothyroidism in persons with chronic kidney disease (CKD) not requiring chronic dialysis is not well defined."
The investigators analyzed cross-sectional data from 3089 adult outpatients consecutively referred by general practitioners for routine blood testing during the last 2 years. The abbreviated Modification of Diet in Renal Disease equation was used to estimate glomerular filtration rate (GFR), and multivariable logistic regression was used to characterize the independent association between prevalent subclinical primary hypothyroidism and estimated GFR.
Of 3089 adult participants, 293 (9.5%) had subclinical primary hypothyroidism, and 277 (9%) had an estimated GFR of less than 60 mL/minute per 1.73 m2. Subclinical primary hypothyroidism became more prevalent as GFR decreased, with a prevalence of 7% at an estimated GFR of more than 90 mL/minute per 1.73 m2, and 17.9% at an estimated GFR of less than 60 mL/minute per 1.73 m2 (P < .0001 for trend).
After adjustment for age; sex; and fasting plasma glucose, total cholesterol, and triglyceride concentrations, the odds of subclinical primary hypothyroidism were increased in participants with an estimated GFR of less than 60 mL/minute per 1.73 m2 vs participants with an estimated GFR of more than 60 mL/minute per 1.73 m2.
"These findings suggest that subclinical primary hypothyroidism is a relatively common condition (~18%) among persons with CKD not requiring chronic dialysis, and it is independently associated with progressively lower estimated GFR in a large cohort of unselected outpatient adults," the study authors write. "Future clinical and experimental studies should explore potential causal mechanisms linking subclinical primary hypothyroidism and CKD."
Limitations of this study include cross-sectional design, precluding determination of causal or temporal relationships between subclinical primary hypothyroidism and kidney disease; definition of kidney function based on estimated GFR vs more precise markers such as iothalamate clearance; inability to identify nonthyroidal and thyroidal causes of subclinical hypothyroidism; possible misclassification resulting from use of automated databases; and lack of data on comorbid medical conditions and current use of thyroid medications.
"The possible adverse effects of subclinical hypothyroidism on cardiovascular risk associated with CKD are presently unknown," the study authors conclude. "Whether adult patients with CKD should be routinely screened for subclinical primary hypothyroidism requires further investigation."
The study authors have disclosed no relevant financial relationships.
Clin J Am Soc Nephrol. Published online June 11, 2008.
Subclinical primary hypothyroidism, which is defined biochemically as elevated serum thyrotropin (TSH) levels but normal free thyroxine levels, has been associated with markers of cardiovascular risk and cardiac impairment. It is also a strong predictor of all-cause mortality in patients requiring long-term dialysis and is a risk factor for nephropathy and cardiovascular events in patients with type 2 diabetes.
To date, quantitative evidence is limited with regard to the prevalence of subclinical primary hypothyroidism in clinical populations, such as large non-US cohorts with varying ranges of estimated GFR. Therefore, the goal of the present study was to estimate the prevalence of subclinical primary hypothyroidism at different levels of kidney function.